Getinge AB Class B GNGBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $21.25
- Day Range
- $21.17–21.17
- 52-Week Range
- $16.76–24.84
- Bid/Ask
- $20.41 / $22.73
- Market Cap
- $5.77 Bil
- Volume/Avg
- 150 / 202
Key Statistics
- Price/Earnings (Normalized)
- 25.58
- Price/Sales
- 1.90
- Dividend Yield (Trailing)
- 1.90%
- Dividend Yield (Forward)
- 0.17%
- Total Yield
- 1.90%
Company Profile
Getinge, headquartered in Gothenburg, Sweden, manufactures a wide range of products for use in acute care, surgical, and life sciences in the hospital, pharmaceutical, and research settings. The company reports in three segments: acute care therapies (52% of revenue), surgical workflows (34%), and life sciences (14%). Product areas include ventilators, surgical stents, life support systems, sterilizers, surgical tables, and sterile transfer systems. Getinge derives revenue from a broad geographic footprint, with the Americas accounting for 45% of sales (U.S. 33% of sales), Asia-Pacific 25%, and Europe, Middle East, and Africa the remaining 30%.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Mid Core
- Total Number of Employees
- 11,739
- Website
- https://www.getinge.com
Competitors
Valuation
|
Metric
|
GNGBF
|
MDT
|
TFX
|
|---|---|---|---|
Price/Earnings (Normalized) | 25.58 | 14.95 | 15.49 |
Price/Book Value | 1.91 | 2.08 | 2.24 |
Price/Sales | 1.90 | 3.33 | 3.36 |
Price/Cash Flow | 13.41 | 14.72 | 16.05 |
Price/Earnings
GNGBF
MDT
TFX
Financial Strength
|
Metric
|
GNGBF
|
MDT
|
TFX
|
|---|---|---|---|
Quick Ratio | 0.75 | 1.46 | 1.10 |
Current Ratio | 1.26 | 2.30 | 2.32 |
Interest Coverage | 7.87 | 8.86 | 5.95 |
Quick Ratio
GNGBF
MDT
TFX
Profitability
|
Metric
|
GNGBF
|
MDT
|
TFX
|
|---|---|---|---|
Return on Assets (Normalized) | 4.50% | 7.75% | 5.96% |
Return on Equity (Normalized) | 7.71% | 13.75% | 10.10% |
Return on Invested Capital (Normalized) | 6.95% | 9.87% | 7.98% |
Return on Assets
GNGBF
MDT
TFX
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Hffgpkz | Xdxbb | $184.4 Bil | |
SYK
| Stryker Corp | Cjzxhcwhg | Xnd | $125.0 Bil | |
MDT
| Medtronic PLC | Rgwmkgpp | Jdpqt | $107.4 Bil | |
BSX
| Boston Scientific Corp | Xlhhvtx | Gbxdk | $106.1 Bil | |
EW
| Edwards Lifesciences Corp | Jwvchrcwn | Wkrtgw | $50.8 Bil | |
DXCM
| DexCom Inc | Wqlmrnqn | Wjhtf | $49.9 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Fpknqkrckk | Prtj | $24.6 Bil | |
PHG
| Koninklijke Philips NV ADR | Fkjklrqj | Llklvgr | $24.4 Bil | |
ALGN
| Align Technology Inc | Thqlxbrwj | Dyysmyz | $21.4 Bil | |
PODD
| Insulet Corp | Gpndskhfy | Wzsjvds | $11.9 Bil |